Eli Lilly and Company (LLY) vs Verisk Analytics, Inc. (VRSK)
A side-by-side comparison of Eli Lilly and Company and Verisk Analytics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: LLY is classified in Healthcare; VRSK is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
LLY
Eli Lilly and Company
$1,222.61HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
VRSK
Verisk Analytics, Inc.
$212.26TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — LLY vs VRSK
growth of $100 · dividends reinvested · last 17yLLY +5458.0%VRSK +698.7%LLY compounded faster
Log scale — wide-divergence pair
LLY VRSK
LLY vs VRSK: by the numbers
- •LLY is the larger company ($1.15T vs $27.81B market cap).
- •VRSK trades at the lower trailing earnings multiple (31.46 vs 42.54 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 29.34% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 1.92% CAGR).
- •VRSK pays the higher dividend yield (0.92% vs 0.54%).
Metrics side by side
Valuation
| Metric | LLY | VRSK |
|---|---|---|
| P/E ratio | 42.54 | 31.46 |
| Forward P/E | 34.10 | 26.96 |
| P/S ratio | 14.85 | 9.01 |
| P/B ratio | 34.39 | 92.99 |
| PEG ratio | 0.49 | 3.81 |
| EV / EBITDA | 31.98 | 18.83 |
| FCF yield | 1.27% | 4.03% |
Profitability
| Metric | LLY | VRSK |
|---|---|---|
| Gross margin | 83.51% | 67.44% |
| Operating margin | 45.87% | 44.87% |
| Net margin | 34.98% | 29.34% |
| ROE | 81.01% | 293.95% |
| ROIC | 30.20% | 19.56% |
Dividends
| Metric | LLY | VRSK |
|---|---|---|
| Dividend yield | 0.54% | 0.92% |
| Payout ratio | 28.09% | 29.19% |
Growth (annualized)
| Metric | LLY | VRSK |
|---|---|---|
| Revenue CAGR (5Y) | 23.17% | 1.92% |
| EPS CAGR (5Y) | 28.88% | 8.25% |
| FCF CAGR (5Y) | 19.54% | 4.58% |
| Total return CAGR (5Y) | 38.81% | 2.75% |
Frequently asked
- Which has the lower trailing P/E, LLY or VRSK?
- VRSK has the lower trailing P/E: LLY trades at 42.54 and VRSK at 31.46. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, LLY or VRSK?
- Over the past five years, LLY grew revenue faster — LLY at a 23.17% CAGR versus VRSK at 1.92%.
- Does LLY or VRSK pay a bigger dividend?
- LLY yields 0.54% and VRSK yields 0.92% based on trailing dividends and the latest price.
- Is LLY or VRSK more profitable?
- LLY runs the higher net margin — LLY at 34.98% versus VRSK at 29.34%.
- How have LLY and VRSK total returns compared?
- Over the past 10 years, LLY delivered 32.66% and VRSK delivered 9.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eli Lilly and P/E ratioVerisk Analytics P/E ratioEli Lilly and dividend yieldVerisk Analytics dividend yieldEli Lilly and ROEVerisk Analytics ROEEli Lilly and operating marginVerisk Analytics operating marginEli Lilly and revenue growthVerisk Analytics revenue growthEli Lilly and free cash flowVerisk Analytics free cash flow
Eli Lilly and & Verisk Analytics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.